AMLN Amylin Pharmaceuticals, Inc. (MM)

SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the Lehman Brothers Small Cap Conference on Thursday, November 17, 2004 at 2:15 p.m. PT in Carlsbad, California. Daniel M. Bradbury, Chief Operating Officer of Amylin Pharmaceuticals, will be providing a corporate overview. The live presentation and breakout session will be webcast, and recordings will be made available following the event. The webcasts and recordings will be accessible through Amylin's corporate website, located at http://www.amylin.com/. To access the live webcasts, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software. Amylin Pharmaceuticals is committed to improving the lives of people with diabetes and other metabolic diseases through the discovery, development and commercialization of innovative, cost-effective medicines. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Alice Bahner, Executive Director, Investor Relations of Amylin Pharmaceuticals, Inc., +1-858-642-7272 Web site: http://www.amylin.com/

Copyright